The Japan Working Group for the Assessment That the Alpha-glucosidase-inhibitor Blocks Cardiac Events in Patients With Myocardial Infarction and IGT

The Japan Working Group for the Assessment That the Alpha-glucosidase-inhibitor Blocks Cardiac Events in Patients With Myocardial Infarction and IGT - ABC Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-C000000090

Enrollment

1570

Registered

2005-08-31

Start date

2005-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients With Myocardial Infarction and IGT

Interventions

In the voglibose group, voglibose will be prescribed at 0.6mg three times daily. In control group, each participated doctor will instruct patients on a weight reduction or weight maintenance diet, and

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Impaired Glucose Tolerance 2.History of myocardial infarction

Exclusion criteria

Exclusion criteria: 1.Type I diabetes 2.History of coronary artery bypass graft 3.Severe liver and/or kidney dysfunction 4.History of allergic response to drugs 5.arteriosclerosis obliterans

Design outcomes

Primary

Measure	Time frame
1.Cardiovascular mortality 2.Hospitalization due to cardiovascular events	—

Secondary

Measure	Time frame
(1) All cause mortality (2) Hospitalization due to coronary artery disease (3) Progression of IGT to diabetes (4) Development or deterioration of either hypertension or hyperlipidemia (5) Deterioraion of renal function (6) Hospitalization due to cerebrovascular disease (7) Hospitalization due to heart failure	—

Countries

Japan

Contacts

Public ContactMasafumi Kitakaze

Clinical Study Support Center Japan (CSSCJ) ABC office

kitakaze@zf6.so-net.ne.jp06-6836-5012

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026